Sign In
Buy VTR
$79.05
-1.10 (-1.37%)
At Close: Jun 03, 2026
Ventas, Inc. (VTR) Q2 2023 Earnings Call Transcript
02:19pm, Friday, 04'th Aug 2023
Ventas, Inc. (NYSE:VTR ) Q2 2023 Earnings Conference Call August 4, 2023 10:00 AM ET Company Participants BJ Grant - Senior Vice President, Investor Relations Debra Cafaro - Chairman and CEO Justin Hu
Ventas' (VTR) Q2 FFO Beats, SHOP NOI Up, '23 View Revised
09:47am, Friday, 04'th Aug 2023
Ventas (VTR) posts solid Q2 results on better-than-anticipated revenues. The same-store cash NOI rises year over year on strong performance across the portfolio.
Is a Beat in Store for Ventas (VTR) This Earnings Season?
10:28am, Wednesday, 02'nd Aug 2023
Favorable operating trends of the senior housing operating portfolio and robust demand for its life-science real-estate assets are likely to have benefited Ventas' (VTR) Q2 earnings.
Ventas Announces Second Quarter 2023 Earnings Date and Conference Call
05:35pm, Wednesday, 19'th Jul 2023
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) will issue its second quarter 2023 earnings release after the close of trading on the New York Stock Exchange on
Ventas: Low Price And Fundamental Growth Beget Value
08:30am, Saturday, 24'th Jun 2023
Ventas is a diversified healthcare REIT with growth opportunities and a 4.1% dividend yield, trading at a forward P/FFO of 14.9. The company's senior housing operating portfolio (SHOP) has seen a stro
Ventas: Blowout Performance From SHOP
03:30pm, Friday, 23'rd Jun 2023
Ventas had a solid Q1-2023, with SHOP NOI expanding by 17%. The FFO though declined, and we explain why. We think SHOP will do well over the next 12 months as occupancies rise.
Here's Why Ventas (VTR) is an Apt Pick for Your Portfolio
11:54am, Friday, 23'rd Jun 2023
A rise in healthcare spending by senior citizens, accretive investments in the R&I business and office segment, and a solid balance sheet imply an optimistic near-term scenario for Ventas (VTR).
Why Is Ventas (VTR) Down 3.3% Since Last Earnings Report?
12:34pm, Wednesday, 07'th Jun 2023
Ventas (VTR) reported earnings 30 days ago. What's next for the stock?
Elon Musk Says Home Prices Will Plummet -- But This Type of Real Estate is Practically Minting Money for Investors
05:53am, Wednesday, 07'th Jun 2023
Musk predicts that housing prices will fall, although some disagree with his view. One area of real estate is proving to be especially resilient.
Ventas, Inc. (VTR) CEO Debra Cafaro presents at The Nareit REITweek 2023 Investor Conference Call (Transcript)
06:00pm, Tuesday, 06'th Jun 2023
Ventas, Inc. (NYSE:VTR ) The Nareit REITweek 2023 Investor Conference Call June 6, 2023 2:15 PM ET Company Participants BJ Grant - Senior Vice President, Investor Relations Debra Cafaro - Chairman and
Ventas to Present at Nareit's REITweek 2023 Investor Conference
04:18pm, Friday, 02'nd Jun 2023
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will make a presentation regarding the Company at Nareit's REITweek 2023 Investor
Should You Retain Ventas (VTR) Stock in Your Portfolio Now?
12:15pm, Wednesday, 31'st May 2023
Ventas (VTR) stands to gain from a diverse healthcare real estate portfolio, rebounding senior housing market and biopharma opportunities. Yet, tenant concentration and high interest rates remain conc
Ventas' (VTR) Q1 FFO and Revenues Beat, SHOP NOI Increases
10:43am, Tuesday, 09'th May 2023
Ventas's (VTR) Q1 earnings outshine estimates on better-than-anticipated revenues. The SHOP same-store cash NOI improves on strong pricing power and margin expansion.
Ventas (VTR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
07:45pm, Monday, 08'th May 2023
While the top- and bottom-line numbers for Ventas (VTR) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to
Ventas (VTR) to Post Q1 Earnings: Is a Beat in the Cards?
12:09pm, Friday, 05'th May 2023
Ventas' (VTR) Q1 earnings are likely to have benefited from the positive operating trends of its senior housing operating portfolio and high demand for life-science real-estate assets.
